Skip to content
Screener

Aurinia Pharmaceuticals AUPH Visp, Switzerland — Interest Expense

Similar metrics at other companies

Shake Shack logo
SHAKFinance Lease Interest Expense
$212K-8.2%
CNB Financial logo
CCNEFinance Lease Interest Expense
$238K+7.2%
Diversified Energy logo
DECFinance Lease Interest Expense
$971.75K+52.6%
Insmed logo
INSMFinance Lease Interest Expense
$446K-12.2%
ARH
ARHSFinance Lease Interest Expense
$1.28M-0.1%
GigaCloud Technology logo
GCTFinance Lease Interest Expense
$24K+71.4%

Other financials

Income statement

See full
Revenue$83.2M+18.9%
Gross profit$76.7M+21.9%
Operating income$46.3M+131%
Net income$37.4M+73.9%
EPS (diluted)$0.28+75.0%

Balance sheet

See full
Cash & equivalents$179.8M+239%
Total debt$80.6M-17.7%
Total equity$614.9M+83.4%
Total assets$792.3M+57.6%

Cash flow

See full
Operating cash flow$52.6M+18.8%

Valuation

See full
Market cap$2.07B+35.7%
Enterprise value$1.98B+25.5%
P/E6.6×-18.6×
P/S6.7×+0.8×

Profitability

See full
Gross margin90.4%+0.8pp
Operating margin48.4%+28.4pp
Net margin100.8%+77.5pp

Returns & leverage

See full
Return on equity66.1%+48.8pp
Debt / equity0.1×-0.2×
Current ratio5.4×+0.2×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseInterestExpense.

The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:16 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001600620-26-000062

For each of the three months ended June 30, 2026 and 2025, finance lease expense related to the amortization of finance ROU lease assets was $4.4 million. For the six months ended June 30, 2026 and 2025, finance lease expense related to the amortization of finance ROU lease assets was $8.7 million and $8.8 million, respectively. For the three months ended June 30, 2026 and 2025, interest expense on finance lease liabilities was $0.9 million and $1.1 million, respectively. For the six months ended June 30, 2026 and 2025, interest expense on finance lease liabilities was $2.0 million and $2.2 million, respectively.

Item 1. Financial Statements.

FAQ

What is Aurinia Pharmaceuticals's visp, switzerland — interest expense?
Aurinia Pharmaceuticals (AUPH) reported visp, switzerland — interest expense of $900K in Q2 2026.
How has Aurinia Pharmaceuticals's visp, switzerland — interest expense changed year-over-year?
Aurinia Pharmaceuticals's visp, switzerland — interest expense decreased by 18.2% year-over-year, from $1.1M to $900K.
What does visp, switzerland — interest expense mean?
Captures the interest costs incurred specifically from finance lease liabilities or related debt obligations within the Visp, Switzerland segment. This expense reflects the cost of financing the assets used in this region and impacts the segment's overall profitability. Monitoring this helps investors understand the financial burden of the company's regional leasing strategy.

Ask your AI about Aurinia Pharmaceuticals's visp, switzerland — interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude